pepmg_

Study summary · research use only

[The effect of thymogen on the heart in ischemia and reperfusion]

Observational · animal · Eksperimental'naia i klinicheskaia farmakologiia · 1997 · PMID 9324392

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

In this study using an isolated heart model, with the species not specified, the anti-ischemic properties of thymogen were examined. The abstract reports that its cardioprotective effect was described as higher than that of dalargin and verapamil, and that the anti-ischemic action of thymogen was realized without participation of opiate receptors and without blockade of calcium entry into cardiomyocytes.

Abstract

The anti-ischemic properties of thymogen were studied on an isolated heart model. Its cardioprotective effect was higher than that of dalargin and verapamil. The mechanism of the thymogen anti-ischemic action is realized without the participation of the opiate receptors and blockade of calcium entrance into the cardiomyocytes.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.